{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T08:13:01Z","timestamp":1791274381313,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,7,1]],"date-time":"2006-07-01T00:00:00Z","timestamp":1151712000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2006,7]]},"DOI":"10.1124\/jpet.106.102830","type":"journal-article","created":{"date-parts":[[2006,4,6]],"date-time":"2006-04-06T13:56:36Z","timestamp":1144331796000},"page":"455-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Transport Characteristics of a Novel Peptide Transporter 1 Substrate, Antihypotensive Drug Midodrine, and Its Amino Acid Derivatives"],"prefix":"10.1016","volume":"318","author":[{"given":"Masahiro","family":"Tsuda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Terada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Irie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Katsura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumu","family":"Niida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Tomita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobutaka","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichi","family":"Inui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/jpet.106.102830_bib1","doi-asserted-by":"crossref","unstructured":"Beauchamp LM, Orr GF, de Miranda P, Burnette T, and Krenitsky (1992) Amino acid ester prodrugs of acyclovir. Antiviral Chem Chemother 3: 157-164.","DOI":"10.1177\/095632029200300305"},{"key":"10.1124\/jpet.106.102830_bib2","doi-asserted-by":"crossref","unstructured":"Daniel H (2004) Molecular and integrative physiology of intestinal peptide transport. Annu Rev Physiol 66: 361-384.","DOI":"10.1146\/annurev.physiol.66.032102.144149"},{"key":"10.1124\/jpet.106.102830_bib3","doi-asserted-by":"crossref","unstructured":"Daniel H and Kottra G (2004) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. Pflueg Arch Eur J Physiol 447: 610-618.","DOI":"10.1007\/s00424-003-1101-4"},{"key":"10.1124\/jpet.106.102830_bib4","doi-asserted-by":"crossref","unstructured":"Han H, de Vrueh RL, Rhie JK, Covitz KM, Smith PL, Lee CP, Oh DM, Sad\u00e9e W, and Amidon GL (1998) 5\u2032-Amino acid esters of antiviral nucleosides, acyclovir and AZT are absorbed by the intestinal PEPT1 peptide transporter. Pharm Res (NY) 15: 1154-1159.","DOI":"10.1023\/A:1011919319810"},{"key":"10.1124\/jpet.106.102830_bib5","doi-asserted-by":"crossref","unstructured":"Inui K and Terada T (1999) Dipeptide transporters, in Membrane Transporters as Drug Targets (Amidon GL and Sad\u00e9e W eds) pp 269-288, Academic\/Plenum Publishers, New York.","DOI":"10.1007\/0-306-46812-3_10"},{"key":"10.1124\/jpet.106.102830_bib6","doi-asserted-by":"crossref","unstructured":"Inui K, Yamamoto M, and Saito H (1992) Transepithelial transport of oral cephalosporins by monolayers of intestinal epithelial cell line Caco-2: specific transport systems in apical and basolateral membranes. J Pharmacol Exp Ther 261: 195-201.","DOI":"10.1016\/S0022-3565(25)10961-0"},{"key":"10.1124\/jpet.106.102830_bib7","doi-asserted-by":"crossref","unstructured":"Irie M, Terada T, Katsura T, Matsuoka S, and Inui K (2005) Computational modeling of H+-coupled peptide transport via human PEPT1. J Physiol (Lond) 565: 429-439.","DOI":"10.1113\/jphysiol.2005.084582"},{"key":"10.1124\/jpet.106.102830_bib8","doi-asserted-by":"crossref","unstructured":"Irie M, Terada T, Sawada K, Saito H, and Inui K (2001) Recognition and transport characteristics of nonpeptidic compounds by basolateral peptide transporter in Caco-2 cells. J Pharmacol Exp Ther 298: 711-717.","DOI":"10.1016\/S0022-3565(24)29432-5"},{"key":"10.1124\/jpet.106.102830_bib9","doi-asserted-by":"crossref","unstructured":"Kennedy DJ, Leibach FH, Ganapathy V, and Thwaites DT (2002) Optimal absorptive transport of the dipeptide glycylsarcosine is dependent on functional Na+\/H+ exchange activity. Pflueg Arch Eur J Physiol 445: 139-146.","DOI":"10.1007\/s00424-002-0910-1"},{"key":"10.1124\/jpet.106.102830_bib10","doi-asserted-by":"crossref","unstructured":"Mackenzie B, Fei YJ, Ganapathy V, and Leibach FH (1996) The human intestinal H+\/oligopeptide cotransporter hPEPT1 transports differently-charged dipeptides with identical electrogenic properties. Biochim Biophys Acta 1284: 125-128.","DOI":"10.1016\/S0005-2736(96)00170-8"},{"key":"10.1124\/jpet.106.102830_bib11","doi-asserted-by":"crossref","unstructured":"Matsumoto S, Saito H, and Inui K (1995) Transport characteristics of ceftibuten, a new cephalosporin antibiotic, via the apical H+\/dipeptide cotransport system in human intestinal cell line Caco-2: regulation by cell growth. Pharm Res (NY) 12: 1483-1487.","DOI":"10.1023\/A:1016235404598"},{"key":"10.1124\/jpet.106.102830_bib12","doi-asserted-by":"crossref","unstructured":"Mukai S and Lipsitz LA (2002) Orthostatic hypotension. Clin Geriatr Med 18: 253-268.","DOI":"10.1016\/S0749-0690(02)00008-3"},{"key":"10.1124\/jpet.106.102830_bib13","doi-asserted-by":"crossref","unstructured":"Pan X, Terada T, Okuda M, and Inui K (2003) Altered diurnal rhythm of intestinal peptide transporter by fasting and its effects on the pharmacokinetics of ceftibuten. J Pharmacol Exp Ther 307: 626-632.","DOI":"10.1124\/jpet.103.055939"},{"key":"10.1124\/jpet.106.102830_bib14","doi-asserted-by":"crossref","unstructured":"Prakash S, Garg AX, Heidenheim AP, and House AA (2004) Midodrine appears to be safe and effective for dialysis-induced hypotension: a systematic review. Nephrol Dial Transplant 19: 2553-2558.","DOI":"10.1093\/ndt\/gfh420"},{"key":"10.1124\/jpet.106.102830_bib15","doi-asserted-by":"crossref","unstructured":"Saito H and Inui K (1993) Dipeptide transporters in apical and basolateral membranes of the human intestinal cell line Caco-2. Am J Physiol 265: G289-G294.","DOI":"10.1152\/ajpgi.1993.265.2.G289"},{"key":"10.1124\/jpet.106.102830_bib16","doi-asserted-by":"crossref","unstructured":"Saito H, Okuda M, Terada T, Sasaki S, and Inui K (1995) Cloning and characterization of a rat H+\/peptide cotransporter mediating absorption of beta-lactam antibiotics in the intestine and kidney. J Pharmacol Exp Ther 275: 1631-1637.","DOI":"10.1016\/S0022-3565(25)12227-1"},{"key":"10.1124\/jpet.106.102830_bib17","doi-asserted-by":"crossref","unstructured":"Sawada K, Terada T, Saito H, Hashimoto Y, and Inui K (1999) Recognition of l-amino acid ester compounds by rat peptide transporters PEPT1 and PEPT2. J Pharmacol Exp Ther 291: 705-709.","DOI":"10.1016\/S0022-3565(24)35157-2"},{"key":"10.1124\/jpet.106.102830_bib18","doi-asserted-by":"crossref","unstructured":"Sugawara M, Huang W, Fei YJ, Leibach FH, Ganapathy V, and Ganapathy ME (2000) Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci 89: 781-789.","DOI":"10.1002\/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7"},{"key":"10.1124\/jpet.106.102830_bib19","doi-asserted-by":"crossref","unstructured":"Terada T and Inui K (2004) Peptide transporters: structure, function, regulation, and application for drug delivery. Curr Drug Metab 5: 85-94.","DOI":"10.2174\/1389200043489153"},{"key":"10.1124\/jpet.106.102830_bib20","doi-asserted-by":"crossref","unstructured":"Terada T, Saito H, Mukai M, and Inui K (1996) Identification of the histidine residues involved in substrate recognition by a rat H+\/peptide cotransporter, PEPT1. FEBS Lett 394: 196-200.","DOI":"10.1016\/0014-5793(96)00952-0"},{"key":"10.1124\/jpet.106.102830_bib21","doi-asserted-by":"crossref","unstructured":"Terada T, Saito H, Mukai M, and Inui K (1997) Recognition of beta-lactam antibiotics by rat peptide transporters, PEPT1 and PEPT2, in LLC-PK1 cells. Am J Physiol 273: F706-F711.","DOI":"10.1152\/ajprenal.1997.273.5.F706"},{"key":"10.1124\/jpet.106.102830_bib22","doi-asserted-by":"crossref","unstructured":"Terada T, Sawada K, Saito H, and Inui K (1999) Functional characteristics of basolateral peptide transporter in the human intestinal cell line Caco-2. Am J Physiol 276: G1435-G1441.","DOI":"10.1152\/ajpgi.1999.276.6.G1435"},{"key":"10.1124\/jpet.106.102830_bib23","doi-asserted-by":"crossref","unstructured":"Yang CY, Dantzig AH, and Pidgeon C (1999) Intestinal peptide transport systems and oral drug availability. Pharm Res (NY) 16: 1331-1343.","DOI":"10.1023\/A:1018982505021"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524328022?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356524328022?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/jpet.106.102830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T21:56:19Z","timestamp":1740002179000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356524328022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,7]]}},"alternative-id":["S0022356524328022"],"URL":"https:\/\/doi.org\/10.1124\/jpet.106.102830","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2006,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transport Characteristics of a Novel Peptide Transporter 1 Substrate, Antihypotensive Drug Midodrine, and Its Amino Acid Derivatives","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/jpet.106.102830","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2006 The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}